Activation of inactive plasma renin by tissue kallikreins

The Journal of Clinical Endocrinology and Metabolism
F H DerkxM A Schalekamp

Abstract

It has been reported that inactive (acid-activable) human renin could be converted into the active form by adding urinary kallikrein to acid-pretreated plasma. Without prior acidification, however, only a small portion of the total amount of inactive renin present in plasma was converted (activated) by kallikrein, probably because native plasma contains protease (kallikrein) inhibitors that are destroyed by acid. We have separated inactive and active renin by DEAE-Sepharose column chromatography of normal human plasma at pH 7.5 and a linearly increasing sodium gradient. Inactive renin isolated in this way could be activated at pH 7.5 by highly purified pancreas and urinary kallikreins. With the semipurified preparation of inactive renin, prior acidification was not required for obtaining virtually complete activation by kallikrein. The kallikreins were effective at concentrations as low as 1 x 10(-8) mol/liter. It is therefore possible that one or more tissue kallikreins act as physiological activators of inactive renin.

Citations

Jan 1, 1981·Pflügers Archiv : European journal of physiology·K TomitaF Sakai
Nov 28, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·A H M Nurun Nabi, Fumiaki Suzuki
Nov 25, 2003·Kidney International·Andreas RohrwasserJ M Lalouel
Aug 1, 1991·British Journal of Clinical Pharmacology·R J MacFadyenJ L Reid
Feb 1, 1991·British Journal of Clinical Pharmacology·A D BainbridgeJ L Reid
Mar 1, 1992·British Journal of Clinical Pharmacology·G J MacpheeJ L Reid
Aug 1, 1992·British Journal of Clinical Pharmacology·R J MacFadyenJ L Reid
Mar 1, 1993·British Journal of Clinical Pharmacology·R J MacFadyenJ L Reid
Oct 1, 1994·British Journal of Clinical Pharmacology·R J MacFadyenJ L Reid
Jan 1, 1981·European Journal of Clinical Pharmacology·J H de BruynM A Schalekamp
Jan 1, 1980·Clinical and Experimental Hypertension : CHE·F H DerkxM A Schalekamp
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·F H DerkxM A Schalekamp
Aug 1, 1981·Archives of Andrology·D J CravenE M Symonds
Jan 1, 1984·American Journal of Obstetrics and Gynecology·A Y WarrenE M Symonds
May 1, 1986·Kidney International·P J Fuller, J W Funder
Mar 1, 1996·Hypertension·F A NevesJ D Baxter
Oct 28, 2005·Journal of the American Society of Nephrology : JASN·Nicolas PicardPascal Houillier
Mar 1, 1983·The American Journal of Physiology·M KobayashiK Hashiba
May 15, 1981·Biochemical Pharmacology·D R BorgesJ L Prado

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.